Topical glucocorticoid with anti-inflammatory, antipruritic, and vasoconstrictive properties. Thought to act by inducing phospholipase A2 inhibitory proteins, thus controlling biosynthesis of potent mediators of inflammation.
Primary scalp infections (scalp application formulation). Standard considerations.
Use Cautiously in:
Diabetes mellitus, cataracts, glaucoma, or tuberculosis (use of large amounts of high-potency agents may worsen condition).
Patients with pre-existing skin atrophy.
Pregnancy, lactation, or children (chronic high-dose usage may result in adrenal suppression in mother, growth suppression in children; children may be more susceptible to adrenal and growth suppression).